Holen Sie sich die Stockscreener-App
20.83
6.04%
1.22
Schlusskurs vom Vortag:
$19.61
Offen:
$19.72
24-Stunden-Volumen:
83,663
Relative Volume:
0.23
Marktkapitalisierung:
$386.06M
Einnahmen:
$62.81M
Nettoeinkommen (Verlust:
$-13.75M
KGV:
-26.04
EPS:
-0.8
Netto-Cashflow:
$153.00K
1W Leistung:
-4.08%
1M Leistung:
+1.44%
6M Leistung:
+128.02%
1J Leistung:
+298.37%
1-Tages-Spanne:
$19.50
$21.06
1-Wochen-Bereich:
$19.50
$22.25
52-Wochen-Spanne:
$3.78
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
Firmenname
Optimizerx Corp
Sektor
Branche
Telefon
248-651-6558
Adresse
260 CHARLES STREET, WALTHAM, MI
Vergleichen Sie OPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
20.80 | 364.06M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
289.52 | 46.72B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
89.45 | 14.99B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.71 | 12.33B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.78 | 8.01B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.27 | 7.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-02-02 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-11-01 | Eingeleitet | Stifel | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
| 2021-10-18 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-04-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-01-03 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Optimizerx Corp Aktie (OPRX) Neueste Nachrichten
OptimizeRx (OPRX) to Release Earnings on Thursday - MarketBeat
OptimizeRx Corporation stock chart pattern explained2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com
OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Why OptimizeRx Corporation stock attracts global investorsShare Buyback & Capital Protection Trading Alerts - newser.com
OptimizeRx (NASDAQ: OPRX) sets Q2 results call Aug 7 via webcast and dial-in access - Stock Titan
OptimizeRx Corp. Hits New 52-Week High of $21.99, Up 90% Yearly - Markets Mojo
Can OptimizeRx Corporation stock attract ESG capital inflowsJuly 2025 Trends & Short-Term Swing Trade Alerts - newser.com
OptimizeRx Corporation stock outlook for YEARWeekly Earnings Recap & Long-Term Investment Growth Plans - newser.com
Why OptimizeRx Corporation stock appeals to analystsWeekly Gains Report & Weekly Market Pulse Alerts - newser.com
Will OptimizeRx Corporation stock deliver better than expected guidanceWeekly Profit Report & Long-Term Safe Return Strategies - newser.com
What insider trading reveals about OptimizeRx Corporation stockPortfolio Value Report & Capital Efficient Trade Techniques - Fundação Cultural do Pará
Aug Outlook: Why OptimizeRx Corporation stock appeals to analystsJobs Report & Free Safe Capital Growth Stock Tips - Fundação Cultural do Pará
Why analysts upgrade OptimizeRx Corporation stockEarnings Overview Summary & Safe Capital Preservation Plans - Fundação Cultural do Pará
Is now a turning point for OptimizeRx CorporationJuly 2025 Trends & High Conviction Trade Alerts - newser.com
Will OptimizeRx Corporation stock recover faster than marketJuly 2025 Intraday Action & Community Consensus Trade Alerts - newser.com
Is OptimizeRx Corporation stock recession proofJuly 2025 Highlights & Risk Managed Investment Strategies - newser.com
Is OptimizeRx Corporation stock in correction or buying zoneNew Guidance & Safe Entry Trade Reports - newser.com
Weiss Ratings Reaffirms Sell (D-) Rating for OptimizeRx (NASDAQ:OPRX) - MarketBeat
OptimizeRx Stock Delivers Over 90% Gain In Six MonthsA Prescription For Portfolio Growth? - RTTNews
Pattern recognition hints at OptimizeRx Corporation upsideStock Surge & Reliable Momentum Entry Alerts - newser.com
Does OptimizeRx Corporation qualify in momentum factor screening2025 Macro Impact & Free Safe Capital Growth Stock Tips - newser.com
Real time social sentiment graph for OptimizeRx CorporationJuly 2025 Action & High Accuracy Trade Signal Alerts - newser.com
OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET - The Globe and Mail
OptimizeRx Corp. Schedules Conference Call to Discuss Q3 2025 Financial Results - Quiver Quantitative
Nov 6, 4:30 p.m. ET: OptimizeRx to Discuss Q3 2025 Results on Conference Call; replay 12 months - Stock Titan
Finanzdaten der Optimizerx Corp-Aktie (OPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Optimizerx Corp-Aktie (OPRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
190,536 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Sale |
18.75 |
1,620 |
30,375 |
188,916 |
| Stelmakh Edward | Chief Finance & Strat Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
16,623 |
0 |
127,387 |
| Besch Doug | Chief Product & Tech Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
3,325 |
0 |
70,555 |
| Spangler Patrick D | Director |
Aug 28 '25 |
Sale |
17.49 |
11,120 |
194,489 |
44,215 |
1.41%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):